Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series

BACKGROUND: Prostate cancer harboring cyclin-dependent kinase 12 (CDK12) abnormalities is a hot topic due to its distinctive clinical features, such as sensitivity to immune checkpoint inhibitors. In the last few years, precision medicine using comprehensive genome sequencing has become familiar, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwasawa, Tomohiro, Kosaka, Takeo, Yasumizu, Yota, Hongo, Hiroshi, Yanai, Yoshinori, Baba, Yuto, Matsumoto, Kazuhiro, Nakamura, Kohei, Nishihara, Hiroshi, Oya, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700615/
https://www.ncbi.nlm.nih.gov/pubmed/36271301
http://dx.doi.org/10.1007/s10147-022-02248-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700615/
https://www.ncbi.nlm.nih.gov/pubmed/36271301
http://dx.doi.org/10.1007/s10147-022-02248-z

Ejemplares similares